Furthermore, in pancreatic cancer, high expression of FN1 has been linked to poorer survival prognosis and it may serve as a key signaling gene for therapeutic intervention in pancreatic cancer [27]. This evidence concerns the gene FN1 and familial pancreatic carcinoma.